• Contact/
  • Home/

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • Advent Life Sciences
  • Advent Life Sciences

Page 13 of 25

 
<< Start < Prev 8 9 10 11 12 13 14 15 16 17Next >End >>
06.01.2015Versartis Announces Positive 12 Month Data for VRS-317 from Ongoing Extension Study

Press Release

10.11.2014Advent Life Sciences Promotes Kaasim Mahmood to General Partner and Alain Huriez to Partner

Press Release

28.10.2014Advent Life Sciences Raises £145.5M (USD 235M) for its Second Life Sciences Venture Capital Fund

Press Release

05.09.2014BIOCARTIS RAISES EUR 64.5 MILLION (APPROX. USD 85 MILLION)

Press Release

21.03.2014Versartis Announces Pricing of Its Initial Public Offering

Press Release

26.02.2014Bayer’s voluntary cash offer to acquire the entire issued share capital of Algeta is successful

Press Release

19.02.2014Versartis Secures $55 Million in Series E Financing

Press Release

05.02.2014Agenus Prices Public Offering of Common Stock

Press Release

05.02.2014UniQure Announces Pricing of Initial Public Offering

Press Release

05.02.2014Cellnovo launches first Mobile Diabetes Management System at the ATTD Conference in Vienna, Austria

Press Release



  • Privacy Policy
  • Legal and Regulatory Matters

©2022 Advent Life Sciences